Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplant for Malignant Disease
CD34 Stem Cell Selection for Malignant Condition
Sponsor:Investigator initiated study
Enrolling:Male and Female Patients
Maximum Age:22 years old
IRB Number:AAAK8060
U.S. Government ID:NCT02061800
Contact: Desmarie Sherwood: 212-305-7213 /
Additional Study Information:

The purpose of this study is to determine the incidence and severity of acute GVHD following CD34+ selection in children, adolescents and young adults receiving an allogeneic peripheral blood stem cell transplant from a family member or unrelated adult donor for a malignant condition.

Do You Qualify?
Are you less than 22 years of age?YesNo
Do you have a malignant disorder such as CML, AML, MDS, JMML, ALL or lymphoma?YesNo
You may be eligible for this study

Place Holder

Who Can I Contact?
For more information, please contact:
Desmarie Sherwood
Phone: 212-305-7213